Skip to content
Medicines & Healthcare products Regulatory Agency
The National Institute for Biological Standards and Control

Confidence in biological medicines

  • Stay connected
  • Shopping Basket
  • Pay Now
  • Login / Register
  • Home
  • Products
  • Standardisation
  • Control testing
  • Science and research
  • Expert services
  • About us
  • QE2
  • Advanced therapies
  • Virology
  • Bacteriology
  • Biotherapeutics
  • Analytical sciences
  • Infectious Disease Diagnostics
  • A to Z listing
  • Publications
  • Home  /  
  • Science and research  /  
  • Advanced therapies  /  
  • Genomic reference materials  /  
  • Proposed first WHO International Standards for EGFR variants

 

Proposed first WHO International Standards for EGFR variants

NIBSC is currently developing the proposed first WHO International Standards for Variants; four genomic DNAs each homozygous for one common variant. 

These materials are intended as both calibrants in the quantification of clinically-relevant EGFR variants p.L858R (c.2573T>G), p.T790M (c.2369C>T), p.E746_A750del (c.2235_2249del), p.E746_A750del (c.2236_2250del) and as reference materials to validate the performance of biomarker-based oncology diagnostic assays.

We are recruiting laboratories to assess and to support the establishment of these materials. To join our collaborative study, please email our Project Lead, Leandro.lo-cascio@nibsc.org

Key staff
Dr Leandro Lo-Cascio – Group Leader   
Mr Noble Ossai – Scientist 
  • Careers
  • Terms and conditions
  • Accessibility
  • Privacy notice
  • Cookies
  • Sitemap